News
Effective September 26, 2022: Clinical Policies
Fecha: 21/09/22
Superior HealthPlan has updated certain policies to ensure medical necessity review criteria is current and appropriate for members and the scope of services provided. As a result, the following policies are effective on September 26, 2022, at 12:00AM.
Changes in these policies reflect preauthorization requirement amendments that are less burdensome to insureds, physicians, or health care providers.
POLICY | APPLICABLE PRODUCTS | NEW POLICY OVERVIEW OR UPDATED POLICY REVISIONS |
---|---|---|
Bariatric Surgery (CP.MP.37) | Medicaid (STAR, STAR Health, STAR Kids, STAR+PLUS) | Policy updates include:
|
Reduction Mammoplasty and Gynecomastia Surgery (CP.MP.51) | Medicaid (STAR, STAR Health, STAR Kids, STAR+PLUS), CHIP, and Ambetter | Policy updates include:
|
Transcranial Magnetic Stimulation for Treatment Resistant Major Depression (CP.BH.200) | Ambetter | Policy updates include:
|
Trigger Point Injections for Pain Management (CP.MP.169) | Ambetter | Policy updates include:
|
Vagus Nerve Stimulation (CP.MP.12) | Medicaid (STAR, STAR Health, STAR Kids, STAR+PLUS), CHIP, and Ambetter | Policy updates include:
|
To review all policies, please visit Superior’s Clinical, Payment & Pharmacy Policies webpage.
Prior to updates, Medical Clinical policies are reviewed and approved by the Utilization Management Committee.
For questions or additional information, contact Superior HealthPlan Prior Authorization department at 1-800-218-7508.